November 22, 2021
For Immediate Release
Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IK
West Chester, PA (November 22, 2021) —Daicel Chiral Technologies today announced the introduction of CHIRALPAK® IK, adding new selectivity capabilities to the Daicel portfolio.
This new immobilized selector builds on the success of CHIRALPAK IG, one of the most effective chiral chromatography phases used in laboratories worldwide. CHIRALPAK IK applies the same chemical derivatization as CHIRALPAK IG, but using a cellulose polymer rather than an amylose one. “CHIRALPAK IK promises to add new separations of molecules that can be analyzed with Daicel’s series of Immobilized columns,” said Joseph M. Barendt, Ph.D., President of Daicel Chiral Technologies.
In laboratory testing, CHIRALPAK IK adds new separations and enhances some separations already achieved using IG and other selectors. Beginning in November 2021, CHIRALPAK IK will be available in 5-micron particle size, with other sizes coming shortly.
To learn more about CHIRALPAK IK and our new products available CLICK HERE.
###
About Daicel Chiral Technologies
Chiral Technologies, Inc., d/b/a Daicel Chiral Technologies, is the global leader in enantioselective chromatography serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Daicel Chiral Technologies (West Chester, Pa.), the European market through Daicel Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.
Learn more at www.chiraltech.com and www.daicelchiraltech.cn.